, welcome to your Active Aging & Longevity II dashboard!

Portfolia’s 2024 Performance Reports are now available for all funds. COO Tammi Jantzen will present an overview April 3rd on Understanding Performance Reports and K-1s. Register Now to secure your spot.

Live and interactive meetings will be held for Fund Members with Fund management teams from April 20 to May 15. Stay tuned for detailed schedules.

Join the Waitlist

The Portfolia Investor Summit has officially reached capacity. If you’d like to join us, please add your information below. We will be in touch if space becomes available.

Join the Waitlist

As we focus on performance, the Rising America Funds continue to be among our highest performers with Fund I in the top 5% of all venture capital funds of its vintage year. With a strong focus in healthcare and fintech, secure your spot now in Rising America Fund III.

Active Aging Fund II is currently at 1.18x net TPVI, meaning every $1 invested by the fund is worth $1.18. At 14.1% net IRR, this puts Active Aging Fund II in the upper quartile for the U.S. VC market for funds of its vintage year 2022. With 8 active companies in Active Aging Fund II, including L-Nutra, Siren and Xandar Kardian, we expect to see significant future distributions from the fund.

Annual Fund Performance Report

2024 Active Aging & Longevity II Fund Performance Updates

The 2024 financial statements are as of and for December 31, 2024. Please note all updates provided are confidential and not for distribution. To access the file, use password:

2024AAL2Report!

ACCESS THE REPORT

Quarterly Reports

The highlights of Q4 2024 updates as provided by the company. Please note all updates provided are confidential and not for distribution.

To access the file, use password: Q424AAL2!

see the report

Active Aging & Longevity II Portfolio Highlights

The Active Aging Market is estimated to be in excess of $100B worldwide. In the US alone, those over 50 control 80% of US aggregated net worth. Their household wealth is 3x the size of households headed by 25-50-year olds. On the other hand, the longevity market is an emerging space focused on a younger population, exploring ways great and small to extend the length and health of life, from epigenetics to fasting to ‘moon shot’ new technologies. We see it as a related continuum. The Portfolia Active Aging and Longevity Fund II will invest in the products, services, technologies, and platforms in both spaces.

The dashboard is where our innovative model of collaborative, transparent investing comes to life. Your dashboard will provide detailed company information (i.e. company updates, companies in diligence, new investments), recordings of company pitches, and links for upcoming events. The Portfolia platform is designed to bring you as close to the investing process as you’d like to be -- and we hope you’ll join in regularly to lend your business and consumer expertise.

The Companies & Leadership Team

The Portfolia Active Aging & Longevity Fund II is led by a world-class team of highly sophisticated and experienced investors who are leaders in their respective fields, as venture capitalists, angel investors, and innovators. They bring an expert skill-set including sourcing, diligence, deal negotiation, executive recruitment, strategy and governance.

The Companies

Company Logo Gallery

Siren

Siren Care creates neurofabrics that help people avoid potentially fatal complications caused by chronic disease and aging. ‎‏‏‎ ‎‏‎

Xandar Kardian

Healthcare technology company with FDA 510(k) cleared radar sensor that can continuously and autonomously monitoring vital signs ambiently. The technology has been proven in long term care facilities to provide an average of 2-day early deterioration detection time, leading to a better, proactive health monitoring.

Lighthouse Pharmaceuticals

A biopharmaceutical company advancing innovative precision therapeutics targeting debilitating and rare diseases, including dementia, periodontal disease, atherosclerosis, and orodigestive cancers.

L-Nutra

Producer of fast-mimicking products intended to replicate and enhance the body's natural ability to rejuvenate itself, and promote longevity.

Bowe Glow, Inc

DWB pairs a highly-effective Outer Skincare (topical) formulations with nutrient-rich Inner Skincare (ingestible beauty) solutions that work synergistically to give you transformative, clinically-proven results.

Toi Labs

Healthier lives through advanced bathroom technology.

Veana Therapeutics

Privately-held clinical stage, research and development biotechnology company whose primary mission is to develop safe and effective oral medicines that selectively kill cancer cells and can boost the immune response of cancer patients.